While no newer medications have officially been approved as adjunctive therapies in type 1 diabetes, there is one source of hope: Inpefa (sotagliflozin)
My family thought I was getting ready to die. Around the same time she stopped taking Ozempic, Barber was diagnosed with gastroparesis: a condition also known as stomach paralysis that causes the stomach muscles to stop moving food through the digestive tract effectively, potentially leading to vomiting and a number of other GI symptoms
HSA and FSA accounts are accepted, and no insurance or membership is required
If you achieve your goals and tolerate the medication well at 1.0mg or 1.7mg, staying at that dose is reasonable
[1] [4] Common adverse effects include gastrointestinal symptomsnausea, vomiting, diarrhea, constipation, and abdominal painwhich are generally dose-dependent and may diminish over time with continued use